Relevant to: All Prescription Drug Plans, Medicare Advantage-Prescription Drug Plans, Section 1876 Cost Plans, Medicare-Medicaid Plans, and PACE Organizations
This memorandum addresses key technical questions regarding the process for submitting formulary updates for contract year (CY) 2023, including formulary submission windows, information on Formulary Reference File (FRF) updates, line-level decision dates, and plan deadlines to accept or reject CMS line-level decisions. The current CY 2023 FRF, FRF Change Report (CR), Negative Change Request (NCR) Module, and PA/ST Criteria Change Requests are now available.
Click here to download the full guidance as a PDF.